Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
Toshiaki Iba, Julie Helms, Jean M. Connors, et al.
Journal of Intensive Care (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 52
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Thromboinflammation in acute injury: infections, heatstroke, and trauma
Toshiaki Iba, Julie Helms, Marcel Levi, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 1, pp. 7-22
Closed Access | Times Cited: 36
Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management
Henry Sutanto, Gatot Soegiarto
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 225-243
Open Access | Times Cited: 34
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Tracy Y. Wang, Abdus S. Wahed, Alison Morris, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 4, pp. 515-523
Open Access | Times Cited: 28
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
Janis K. Shute
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 584-584
Open Access | Times Cited: 21
Managing sepsis and septic shock in an endothelial glycocalyx-friendly way: from the viewpoint of surviving sepsis campaign guidelines
Toshiaki Iba, Cheryl L. Maier, Julie Helms, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial
Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, et al.
Circulation (2023) Vol. 147, Iss. 25, pp. 1891-1901
Open Access | Times Cited: 20
Cardiovascular Manifestations of the Long COVID Syndrome
Marta Lorente‐Ros, Subrat Das, Joseph Elias, et al.
Cardiology in Review (2023) Vol. Publish Ahead of Print
Closed Access | Times Cited: 18
Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
Hamid Tanzadehpanah, Elham Lotfian, Amir Avan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115321-115321
Open Access | Times Cited: 17
Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?
Toshiaki Iba, Jerrold H. Levy, Cheryl L. Maier, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1541-1549
Closed Access | Times Cited: 6
COVID-19 associated coagulopathy
Cristian M. Niculae
Elsevier eBooks (2025), pp. 353-367
Closed Access
Incidence of Thrombotic Complications in COVID-19 Patients and the Impact of Antithrombotic Therapy on ICU Mortality
Mohamed Foda Hendi, Zeyad Faoor Alrais, Muhammad Shoaib, et al.
Cureus (2025)
Open Access
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4—trauma, burn, obstetrics, acute pancreatitis/liver failure, and others
Mineji Hayakawa, Yoshinobu Seki, Takayuki Ikezoe, et al.
International Journal of Hematology (2025)
Closed Access
Coagulation Profile of Convalescent Plasma Donors and Recipients
Hanna Pitkänen, Tuukka Helin, Tamim Khawaja, et al.
Clinical and Applied Thrombosis/Hemostasis (2025) Vol. 31
Open Access
Positionspapier zum Post-COVID-Syndrom
Elisabeth Schieffer, Denise Hilfiker‐Kleiner, Axel Schlitt, et al.
Deleted Journal (2025)
Closed Access
Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence
Saravanan Subramaniam, Asha Jose, Devin Kenney, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
External Validation of the IMPROVE Risk Score for Predicting Bleeding in Hospitalized COVID-19 Patients
Yuzhi Tao, Feiya Xu, Jing Han, et al.
Journal of General Internal Medicine (2025)
Closed Access
Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
Hideo Wada, Katsuya Shiraki, Hideto Shimpo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7975-7975
Open Access | Times Cited: 15
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection
Andrea Boccatonda, Elena Campello, Chiara Simion, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 12, pp. 1035-1048
Closed Access | Times Cited: 14
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102031-102031
Open Access | Times Cited: 13
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
Bruna Gigante, Jerrold H. Levy, Eric C. M. Van Gorp, et al.
European Heart Journal (2023) Vol. 44, Iss. 32, pp. 3040-3058
Open Access | Times Cited: 12
COVID-19 and the Concept of Thrombo-Inflammation: Review of the Relationship between Immune Response, Endothelium and Coagulation
Emmanuel de Maistre, Philippe Savard, Pierre-Grégoire Guinot
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7245-7245
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top